Aptevo Therapeutics is a biotechnology company focused on oncology (cancer) and hematology (blood disease) therapeutics. The company's core technology is the ADAPTIR? (modular protein technology) platform. The company's product candidates include: APVO436, an ADAPTIR bispecific immunotherapeutic protein targeting CD123, a cell surface receptor expressed on several hematological malignancies and CD3, a component of the T-cell receptor; APVO210, an anti-inflammatory molecule engineered using the company's ADAPTIR platform technology; and ALG.APV-527, a bispecific antibody candidate, featuring a mechanism of action designed to target 4-1BB (CD137) and 5T4, a tumor antigen overexpressed in various types of cancer.

Cadence is a bank holding company. The company is engaged in commercial lending to middle-market customers and provide a range of commercial loans to middle-market commercial businesses, individuals and business owners. The company's loan portfolio includes commercial and industrial loans, residential real estate loans, commercial real estate loans and other consumer loans. The company also provides its customers a variety of deposit products, including checking accounts, savings accounts, money market accounts and other deposit accounts, through multiple channels, including its network of full-service branches, drive-thru branches, ATMs, ITMs, and its online, mobile and telephone banking platforms.

Calix is a provider of cloud and software platforms, systems and software for fiber- and copper-based network architectures. The company is also a provider of software defined access and cloud products focused on access networks and the subscriber. The company's portfolio allows for a range of subscriber services to be provisioned and delivered over a single unified network. The company's access systems can deliver voice and data services, broadband services, mobile broadband, as well as high-definition video and online gaming. The company's premises systems enable communications service providers to manage the smart home and business and provide new services to their device enabled subscribers.

Comfort Systems USA provides mechanical contracting services, which include heating, ventilation and air conditioning (HVAC), plumbing, piping and controls, as well as off-site construction, electrical, monitoring and fire protection. The company provides construction, renovation, expansion, maintenance, repair and replacement services for mechanical and related systems in commercial, industrial and institutional properties. The company's installation business related to newly constructed facilities involves the design, engineering, integration, installation and start-up of mechanical and related systems. The company also provides remote monitoring of temperature, pressure, humidity and air flow for HVAC systems.

Marchex is a call analytics company that helps businesses connect, drive, measure and convert callers into customers. The company's primary product offerings include: Marchex Call Analytics, which is an analytics platform for enterprises; Marchex Display and Video Analytics, which is a product for marketers that buy digital display advertising; Marchex Site Analytics, which is a product for marketers that can drive phone calls from websites; Marchex Social Analytics, which is a product for marketers that buy social media advertising; Marchex Call Marketplace, which is a mobile advertising network for businesses; and Local Leads, which is an advertising solution for small business resellers.

Otelco provides a range of telecommunication services on a retail and wholesale basis. These services include local and long distance calling; network access to and from the company's customers; data transport; digital high-speed internet; cable and Internet Protocol television; other telephone related services; and cloud hosting and managed services. The company provides various communications services that are sold to economically similar customers in a comparable manner of distribution. The company also provides cloud hosting and managed services for small and mid-sized companies who rely on mission-critical software applications.

Soleno Therapeutics is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company's primary candidate, Diazoxide Choline Controlled Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company's research and development efforts are primarily focused on developing its primary candidate, DCCR tablets for the treatment of PWS, through late-stage clinical development.